Exclusive use over of a trademark derived from a generic name of the drug is not permissible
The Division Bench of the Delhi High Court held that a trademark which is derived from a generic name of the drug cannot be granted exclusive use. The High Court dismissed the appeal by Sun Pharmaceuticals Laboratories Ltd. on the ground that there cannot be any monopoly since their mark ‘LETROZ’ is derived from ‘LETROZOLE’, which is an international non-proprietary name of a salt.
To read further details, click here or refer to the below document.
For more details, please contact [email protected]
*In case the document is not visible on the device you are using, please click the link above.
